The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
종목 코드 TOI
회사 이름Oncology Institute Inc
상장일Mar 13, 2020
CEODr. Daniel Virnich, M.D.
직원 수825
유형Ordinary Share
회계 연도 종료Mar 13
주소18000 Studebaker Rd
도시CERRITOS
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호90703
전화15627353226
웹사이트https://theoncologyinstitute.com/
종목 코드 TOI
상장일Mar 13, 2020
CEODr. Daniel Virnich, M.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음